Skip to main content
. Author manuscript; available in PMC: 2022 Sep 12.
Published in final edited form as: World Neurosurg. 2021 Apr 20;151:e185–e191. doi: 10.1016/j.wneu.2021.04.003

Table 2.

Patient Characteristics Stratified by Adenoma Type

Characteristic Non-PP1 Adenoma PP1 Adenoma P Value
Patients 1146 (98.2) 20 (1.71) NA
Sex 0.550
 Female 593 (51.7) 9 (45.0)
 Male 553 (48.3) 11 (55.0)
Age (Years) 51.0 (37.0–63.0) 47.5 (35.0–60.8) 0.821
Size 0.342
 Microadenoma 207 (18.3) 2 (10.0)
 Macroadenoma 927 (81.7) 18 (90.0)
Previous Surgery 0.898
 No 962 (83.9) 17 (85.0)
 Yes 184 (16.1) 3 (15.0)
Future Reoperation 0.910
 No 1082 (94.4) 19 (95.0)
 Yes 64 (5.6) 1 (5.0)
P53 Staining 0.325
 No 97 (28.3) 1 (12.5)
 Yes 246 (71.7) 7 (87.5)
Neoadjuvant RT 0.597
 No 1112 (97.0) 19 (95.0)
 Yes 34 (3.0) 1 (5.0)
Adjuvant RT 0.654
 No 992 (86.6) 18 (90.0)
 Yes 154 (13.4) 2 (10.0)
Resection Extent 0.139
 GTR 725 (64.0) 16 (80.0)
 STR 408 (36.0) 4 (20.0)
MiB Index 2.44 ± 2.29 2.34 ± 1.69 0.846

Data presented as n (%), median (interquartile range), or mean ± standard deviation.

PP1, plurihormonal PIT-1–positive; NA, not applicable; RT, radiotherapy; GTR, gross total resection; STR, subtotal resection.